Can a Text-Message Intervention Reduce Cannabis-Impaired Driving? A New Randomized Trial
| Audience | Patients, families, clinicians, college health professionals, prevention specialists, and readers concerned about cannabis-impaired driving |
| Primary Topic | mobile personalized feedback and motivational text messaging to reduce self-reported driving after cannabis use |
| Source | Read the full source |
Can a Text-Message Intervention Reduce Cannabis-Impaired Driving? A New Randomized Trial
A July 27, 2026 randomized trial found that personalized feedback, with or without interactive text messaging, reduced self-reported cannabis-impaired driving among emerging adults compared with standard information. The trial supports prevention research, not driving after cannabis use.
| Study Type | Phase II, three-arm randomized controlled trial |
| Setting | Western Kentucky University and surrounding community; intervention delivered remotely |
| Participants | 149 emerging adults reporting cannabis-impaired driving at least three times in the prior three months |
| Combined Intervention | Personalized feedback plus one session of interactive motivational-interviewing text messages, n=45 |
| Feedback Only | Personalized feedback, n=50 |
| Control | Standard non-personalized substance-use information, n=54 |
| Primary Outcome | Self-reported number of cannabis-impaired driving episodes in the prior three months |
| Follow-up | Three and six months |
| Published | July 27, 2026 |
| PMID | 42504715 |
| DOI | 10.1111/add.70554 |
Participants were randomized to personalized feedback plus interactive motivational-interviewing text messages, personalized feedback alone, or standard substance-use information.
The primary outcome was the self-reported number of times participants drove after cannabis use during the prior three months, measured at three-month and six-month follow-up.
Compared with the information control, the combined feedback and text-message group reported greater reductions at three months (incidence rate ratio 0.34) and six months (incidence rate ratio 0.40).
The feedback-only group showed a significant reduction at six months compared with control (incidence rate ratio 0.25). The study found no significant between-group change for driving after simultaneous alcohol and cannabis use.
Driving episodes were self-reported, so recall and social-desirability bias are possible. Participants came from one university region and had already reported repeated cannabis-impaired driving, which limits generalizability.
The intervention aimed to change behavior. It did not test whether participants were objectively impaired, whether collisions declined, or whether any post-use interval makes driving safe.
Behavioral prevention and pharmacologic impairment are different questions. An intervention may reduce risky decisions without changing how THC affects reaction time, attention, or judgment.
The null result for driving after combined alcohol and cannabis use suggests that higher-risk polysubstance behavior may require a more intensive or differently targeted approach.
The clinically useful point is that a short, remote conversation may change a dangerous repeated behavior. That is meaningful because counseling about cannabis and driving often stops at a warning, while this study tested a structured intervention.
I would still present this as an early prevention result. Self-reported reductions are encouraging, but they are not equivalent to measured sobriety, safer vehicle performance, or fewer crashes.
How to Read a Behavioral Driving Trial Without Confusing It With an Impairment Study
This trial measured reported driving behavior, not blood THC, simulator performance, or collision risk.
Its strongest contribution is evidence that a brief personalized intervention may alter decisions over several months.
Four Questions for Interpreting the Result
What Was Randomized?
Participants were randomized to two personalized intervention formats or standard information, supporting a causal comparison of those approaches.
What Was Measured?
The endpoint was the recalled number of cannabis-impaired driving occasions, not an objective measure of impairment or driving performance.
When Did Change Appear?
The combined text-message condition separated from control at three months, while feedback alone showed a later effect at six months.
Who Was Studied?
The participants were emerging adults from one regional community who already reported repeated driving after cannabis use.
The Same Study Can Mean Different Things Depending on the Question Being Asked
Scientific papers rarely answer a single question. Patients, clinicians, researchers, policymakers, and critics often read the same data differently. The perspectives below explore how this study looks through several evidence-based lenses.
The Intervention Targets the Decision to Drive
The study does not suggest that cannabis impairment can be talked away.
Its practical aim is to help people plan differently before use and avoid driving afterward.
Personalized Feedback May Beat Generic Advice
Generic safety information may be less effective than feedback tied to a person’s own behavior and goals.
Brief structured counseling may be feasible in college health, primary care, and cannabis medicine.
Use Specific Questions Without Moralizing
Families can ask about rides, passengers, alcohol co-use, and backup plans without assuming that a general warning is enough.
Repeated driving after cannabis use warrants a direct safety conversation.
Self-Report Is Not a Crash Outcome
Participants knew their own behavior and may have remembered or reported it imperfectly.
The study did not verify episodes through vehicle, toxicology, or legal records.
A Scalable Format Deserves Replication
Mobile delivery may reach people who would never attend a formal prevention program.
Replication across regions and settings is needed before broad implementation claims.
The Combined Alcohol Outcome Did Not Improve
The groups did not differ significantly over time in driving after simultaneous alcohol and cannabis use.
That null result may identify a group needing more intensive intervention.
Education Alone May Not Be Enough
Standard information was the comparison condition, while personalized approaches produced the reported differences.
Policy programs should test behavior change rather than count message exposure alone.
Objective Verification Is the Next Step
Future trials could incorporate ecological reporting, vehicle data, biomarkers, ride-use records, and collision or citation outcomes.
Longer follow-up would show whether the behavior change persists.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan
Want to discuss this topic with other patients and caregivers? Join the forum discussion
When a new paper overlaps with earlier CED Clinic coverage, we preserve the chain instead of hiding the overlap. These links point to older related posts so readers can compare what is new, what is repeated, and how the evidence has moved.
Minnesota teen cannabis use fell from 13% in 2013 to 5% in 2025 in statewide student surveys. Important disparities persisted for several groups, including LGBTQ+ youth and youth experiencing poverty. The observational…
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingTHCSafetyPolicyPain Why This Matters Clinicians should understand that…
This digest presents cannabis road safety signals, edible toxicity insights, and pain biomarker findings. Each signal offers valuable information for clinicians and patients. Understanding these signals is crucial for i…
This page discusses 2026 cannabis clinical relevance updates. It includes summaries of 19 articles that scored below the CED clinical relevance threshold. Stay updated on cannabis research and policy developments.
38 cannabis articles clinical relevance scored below the CED threshold in the last 24 hours. Summaries and source links are included for clinical review. This update aids clinicians in tracking recent cannabis research…
This post reviews 30 cannabis articles clinical relevance scored below the CED threshold in the last 24 hours. Summaries and source links are included for clinical insight. Stay informed on the latest cannabis research…
This digest highlights three verified brain and road-safety cannabis signals from 2026 research. It covers THC-positive roadside motorcyclists, MAGL withdrawal biology, and age-dependent CBD effects in epilepsy models….
A JAMA Network Open crossover trial found that cannabis edibles combined with alcohol worsened simulated driving and subjective intoxication more than either substance alone. The study also shows why common field-sobrie…
This post features mixed cannabis industry articles June 22 2026, highlighting 37 cannabis articles scored below the CED clinical relevance threshold. Summaries and source links are included for clinical insights. Stay…
37 cannabis articles clinical relevance scores fell below the CED threshold in the last 24 hours. Summaries and source links are included for each article. This review highlights important clinical relevance updates for…
Frequently Asked Questions
What did this randomized trial test?
It tested personalized feedback with interactive motivational text messages, personalized feedback alone, and standard information for reducing self-reported cannabis-impaired driving.
How many people participated?
The trial enrolled 149 emerging adults who reported driving after cannabis use at least three times in the prior three months.
Did the combined intervention work?
Compared with standard information, the combined feedback and text-message group reported larger reductions at both three and six months.
Did personalized feedback alone work?
The feedback-only group reported a significant reduction compared with control at six months, but not the earlier three-month timepoint described in the abstract.
Were driving episodes objectively verified?
No. The primary outcome was reported through mobile surveys and is subject to recall and reporting bias.
Did the study measure crashes?
No. It did not establish whether collisions, injuries, citations, or objectively measured impairment decreased.
Did the intervention reduce driving after alcohol and cannabis together?
No significant between-group differences over time were found for the secondary outcome involving simultaneous alcohol and cannabis use.
Does this identify a safe waiting time before driving?
No. The study did not test post-use waiting intervals or determine when an individual is safe to drive.
Does this apply to medical cannabis patients?
Not necessarily. The sample was emerging adults with repeated cannabis-impaired driving, so other ages and clinical populations require separate study.
What is the practical takeaway?
Personalized planning may help reduce risky driving decisions, but it does not reverse impairment. The safest plan is to arrange transportation before cannabis use.
